Christoffersen, Berit Østergaard
Kristensen, Camilla Aarup
Lindgaard, Rikke
Kirk, Rikke Kaae
Viuff, Birgitte Martine
Kvist, Peter Helding
Pedersen, Henrik Duelund
Ludvigsen, Trine Pagh
Skovgaard, Tine
Fels, Johannes Josef
Martinussen, Torben
Christiansen, Liselotte Bruun
Cirera, Susanna
Olsen, Lisbeth Høier
Funding for this research was provided by:
LIFEPHARM (Novo Nordisk – LIFE In Vivo Pharmacology Centre) at University of Copenhagen
Article History
Received: 3 October 2022
Accepted: 31 March 2023
First Online: 12 April 2023
Competing interests
: BMV, BØC, HDP, JJF, TPL, RKK and PHK are employees and BØC, JJF, PHK, TPL AND RKK are minor shareholders of Novo Nordisk A/S. All other authors have no conflict of interest. Kits for analysis of plasma and urine NGAL were donated by BioPorto Diagnostics A/S, Hellerup, Denmark.